{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:58:38Z","timestamp":1790092718239,"version":"4.0.1"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970653"],"award-info":[{"award-number":["81970653"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300230"],"award-info":[{"award-number":["82300230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005315","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF0700305"],"award-info":[{"award-number":["2021YFF0700305"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2023J384"],"award-info":[{"award-number":["2023J384"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.mtbio.2025.101726","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T17:52:02Z","timestamp":1744048322000},"page":"101726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy"],"prefix":"10.1016","volume":"32","author":[{"given":"Jiawei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-1379","authenticated-orcid":false,"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2025.101726_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0623-5","article-title":"Cancer Immunotherapy: the Beginning of the End of Cancer?","volume":"14","author":"Farkona","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.mtbio.2025.101726_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2017.300","article-title":"Cancer metabolism, a hope for curing cancer","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.mtbio.2025.101726_bib3","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1007\/s00018-021-03842-6","article-title":"Nanoparticle-based approaches to target the lymphatic system for antitumor treatment","volume":"78","author":"Peng","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib4","doi-asserted-by":"crossref","first-page":"121125","DOI":"10.1016\/j.lfs.2022.121125","article-title":"Tumor-promoting aftermath post-chemotherapy: a focus on breast cancer","volume":"310","author":"Famta","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib5","doi-asserted-by":"crossref","first-page":"1336546","DOI":"10.3389\/fonc.2024.1336546","article-title":"The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer","volume":"14","author":"Sacchi De Camargo Correia","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2025.101726_bib6","doi-asserted-by":"crossref","first-page":"2301770","DOI":"10.1002\/adma.202301770","article-title":"Nanomedicine for T\u2010cell mediated immunotherapy","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib7","doi-asserted-by":"crossref","first-page":"24593","DOI":"10.1021\/acsnano.3c10212","article-title":"Advanced generation therapeutics: biomimetic nanodelivery system for tumor immunotherapy","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0043-1767703","article-title":"Nonoperative management of dMMR\/MSI-H colorectal cancer following neoadjuvant immunotherapy: a narrative review","volume":"36","author":"Yu","year":"2023","journal-title":"Clin. Colon. Rectal. Surg."},{"key":"10.1016\/j.mtbio.2025.101726_bib9","doi-asserted-by":"crossref","first-page":"101149","DOI":"10.1016\/j.apmt.2021.101149","article-title":"Cancer immunotherapy: classification, therapeutic mechanisms, and nanomaterial-based synergistic therapy","volume":"24","author":"Meng","year":"2021","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.mtbio.2025.101726_bib10","doi-asserted-by":"crossref","first-page":"979469","DOI":"10.3389\/fimmu.2022.979469","article-title":"Nanomaterials: A powerful tool for tumor immunotherapy Front Immunol","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib12","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1002\/jcp.29551","article-title":"In situ antitumor vaccination: Targeting the tumor microenvironment","volume":"235","author":"Li","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.mtbio.2025.101726_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrd.2017.254","article-title":"Strategies for mature T cell cancers","volume":"17","author":"Cully","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2025.101726_bib14","doi-asserted-by":"crossref","first-page":"2007363","DOI":"10.1002\/adfm.202007363","article-title":"Strategies for delivering nanoparticles across tumor blood vessels","volume":"31","author":"Sheth","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib15","first-page":"e1914","article-title":"Design and synthesis of bioinspired nanomaterials for biomedical application, WIREs Nanomed","volume":"16","author":"Tang","year":"2024","journal-title":"Nanobiotechnol"},{"key":"10.1016\/j.mtbio.2025.101726_bib16","doi-asserted-by":"crossref","first-page":"952523","DOI":"10.3389\/fbioe.2022.952523","article-title":"Recent advancement of bioinspired nanomaterials and their applications: a review","volume":"10","author":"Wu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.mtbio.2025.101726_bib17","doi-asserted-by":"crossref","first-page":"110298","DOI":"10.1016\/j.msec.2019.110298","article-title":"Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review","volume":"106","author":"He","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.mtbio.2025.101726_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/polym10090983","article-title":"Cell membrane-camouflaged nanoparticles: A promising biomimetic strategy for cancer theragnostics","volume":"10","author":"Uthaman","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.mtbio.2025.101726_bib19","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.3390\/molecules26165103","article-title":"Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma","volume":"26","author":"Fan","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2025.101726_bib20","doi-asserted-by":"crossref","first-page":"2305551","DOI":"10.1002\/smll.202305551","article-title":"Extending the in vivo residence time of macrophage membrane\u2010coated nanoparticles through genetic modification","volume":"19","author":"Duan","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.101726_bib21","doi-asserted-by":"crossref","first-page":"188486","DOI":"10.1016\/j.bbcan.2020.188486","article-title":"Peptides that immunoactivate the tumor microenvironment","volume":"1875","author":"Furukawa","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.mtbio.2025.101726_bib22","first-page":"63","article-title":"NK cell-based tumor immunotherapy","volume":"31","author":"Yang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib23","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1111\/febs.15028","article-title":"The influence of microenvironment on tumor immunotherapy","volume":"286","author":"Zhang","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.mtbio.2025.101726_bib24","doi-asserted-by":"crossref","first-page":"923481","DOI":"10.3389\/fimmu.2022.923481","article-title":"Mapping the tumor microenvironment in TNBC and deep exploration for M1 macrophages-associated prognostic genes","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib25","doi-asserted-by":"crossref","first-page":"624725","DOI":"10.3389\/fimmu.2021.624725","article-title":"Tumor immune microenvironment and its related miRNAs in tumor progression","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib26","doi-asserted-by":"crossref","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","article-title":"Exhausted CD8+T cells in the tumor immune microenvironment: new pathways to therapy","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib27","doi-asserted-by":"crossref","first-page":"109367","DOI":"10.1016\/j.intimp.2022.109367","article-title":"The main battlefield of mRNA vaccine \u2013 tumor immune microenvironment","volume":"113","author":"Li","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.mtbio.2025.101726_bib28","first-page":"1167","article-title":"The prognostic role of M2 tumor-associated macrophages in non-small-cell lung cancer","volume":"37","year":"2022","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.mtbio.2025.101726_bib29","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/cancers16071312","article-title":"The role of natural killer cells in the tumor immune microenvironment of EBV-associated nasopharyngeal carcinoma","volume":"16","author":"Li","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.mtbio.2025.101726_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41419-020-2511-3","article-title":"Anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mtbio.2025.101726_bib31","doi-asserted-by":"crossref","first-page":"1353787","DOI":"10.3389\/fimmu.2024.1353787","article-title":"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.mtbio.2025.101726_bib32","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/CM9.0000000000002525","article-title":"Tumor immune microenvironment-modulated nanostrategy for the treatment of lung cancer metastasis","volume":"136","author":"Zhu","year":"2023","journal-title":"Chin. Med. J. (Engl.)."},{"key":"10.1016\/j.mtbio.2025.101726_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.28.2.113","article-title":"Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells","volume":"28","author":"Fagan","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.mtbio.2025.101726_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14712598.2020.1728250","article-title":"DC-CIK as a widely applicable cancer immunotherapy","volume":"20","author":"Wang","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.mtbio.2025.101726_bib35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.seminoncol.2021.09.002","article-title":"A review of immune checkpoint blockade in breast cancer","volume":"48","author":"Pellegrino","year":"2021","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.mtbio.2025.101726_bib36","doi-asserted-by":"crossref","first-page":"102283","DOI":"10.1016\/j.coi.2023.102283","article-title":"Immune checkpoint receptors in autoimmunity","volume":"80","author":"Burke","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/ijms19051389","article-title":"Cancer immunotherapy: A focus on the regulation of immune checkpoints","volume":"19","author":"Shi","year":"2018","journal-title":"IJMS"},{"key":"10.1016\/j.mtbio.2025.101726_bib38","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1083\/jcb.201810035","article-title":"Immune checkpoint inhibitors","volume":"218","author":"Hui","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mtbio.2025.101726_bib39","first-page":"1321","article-title":"Immune checkpoint inhibitor toxicities, Mayo Clin","volume":"94","author":"Chirila","year":"2019","journal-title":"Proc"},{"key":"10.1016\/j.mtbio.2025.101726_bib40","doi-asserted-by":"crossref","unstructured":"I. Hennig, A.F.P. Dos Reis, A. Wilcock, Immune checkpoint inhibitors: current status, BMJ Support Palliat. Care 14 (2021) e1678-e1683.","DOI":"10.1136\/bmjspcare-2021-002954"},{"key":"10.1016\/j.mtbio.2025.101726_bib41","doi-asserted-by":"crossref","first-page":"106633","DOI":"10.1016\/j.intimp.2020.106633","article-title":"Comprehensive analysis of CTLA-4 in the tumor immune microenvironment of 33 cancer types","volume":"85","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.mtbio.2025.101726_bib42","doi-asserted-by":"crossref","first-page":"106221","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: From mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.mtbio.2025.101726_bib43","first-page":"511","article-title":"Screening and antitumor effect of an anti\u2011CTLA\u20114 nanobody","volume":"39","author":"Wan","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mtbio.2025.101726_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib45","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/1440-1681.13717","article-title":"PD\u2010L1\/PD\u2010L1 signalling promotes colorectal cancer cell migration ability through RAS","volume":"49","author":"Cao","year":"2022","journal-title":"Clin. Exp. Pharma. Physio."},{"key":"10.1016\/j.mtbio.2025.101726_bib46","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","article-title":"IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction","volume":"80","author":"Shiri","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mtbio.2025.101726_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40257-018-0389-y","article-title":"Mechanisms of resistance to immune checkpoint blockade","volume":"20","author":"Liu","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.mtbio.2025.101726_bib48","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mtbio.2025.101726_bib49","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.7150\/jca.31217","article-title":"Efficacy and safety of nivolumab in patients with advanced non-small-cell lung cancer and poor performance status","volume":"10","author":"Katsura","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.mtbio.2025.101726_bib50","doi-asserted-by":"crossref","first-page":"1341584","DOI":"10.3389\/fimmu.2023.1341584","article-title":"Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib51","doi-asserted-by":"crossref","first-page":"1340307","DOI":"10.3389\/fimmu.2024.1340307","article-title":"From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer","volume":"15","author":"Zhou","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib52","doi-asserted-by":"crossref","first-page":"eabl3995","DOI":"10.1126\/sciimmunol.abl3995","article-title":"Size-dependent activation of CAR-T cells","volume":"7","author":"Xiao","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.mtbio.2025.101726_bib53","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/d41573-023-00140-7","article-title":"The next-generation CAR-T therapy landscape","volume":"22","author":"Verma","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2025.101726_bib54","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mtbio.2025.101726_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11899-019-0498-6","article-title":"Industry\u2019s giant leap into cellular therapy: Catalyzing chimeric antigen receptor T cell (CAR-T) immunotherapy","volume":"14","author":"Ittershagen","year":"2019","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.mtbio.2025.101726_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001229","article-title":"Modulating TNF\u03b1 activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia","volume":"8","author":"Ataca Atilla","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2025.101726_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-017-0553-5","article-title":"CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia","volume":"11","author":"Wang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2025.101726_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood-2020-136704","article-title":"Development of CAR-T cell constructs with broad anti-tumor tropism","volume":"136","author":"Mishra","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.mtbio.2025.101726_bib59","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.ymthe.2022.07.021","article-title":"Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-\u03baB\/Icam1 signaling","volume":"30","author":"Zhou","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mtbio.2025.101726_bib60","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/1759-7714.14375","article-title":"CAR\u2010T cell therapy for lung cancer: potential and perspective","volume":"13","author":"Chen","year":"2022","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.mtbio.2025.101726_bib61","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2017-11-785873","article-title":"Vaccine therapy in hematologic malignancies","volume":"131","author":"Avigian","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mtbio.2025.101726_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h988","volume":"350","author":"Butterfield","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.mtbio.2025.101726_bib63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2025.101726_bib64","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/C9NR08958F","article-title":"Nanoparticle formulated vaccines: opportunities and challenges","volume":"12","author":"Lung","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.mtbio.2025.101726_bib65","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3390\/pharmaceutics14102008","article-title":"Biomimetic nanovesicles\u2014sources, design, production methods, and applications","volume":"14","author":"Mougenot","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.101726_bib66","doi-asserted-by":"crossref","first-page":"11765","DOI":"10.1021\/acs.nanolett.4c02816","article-title":"The future of bioinspired innovation: Exploring the potential of nanobiomimetics","volume":"24","author":"Br\u00fcggemann","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.mtbio.2025.101726_bib67","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1039\/C6SC04255D","article-title":"Bioinspired integrated nanosystems based on solid-state nanopores: \u201ciontronic\u201d transduction of biological, chemical and physical stimuli","volume":"8","author":"P\u00e9rez-Mitta","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib68","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/10717544.2021.1938757","article-title":"Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.mtbio.2025.101726_bib69","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/IJN.S442877","article-title":"Biomimetic nano-drug delivery system: an emerging platform for promoting tumor treatment","volume":"2024","author":"Han","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2025.101726_bib70","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2217\/nnm-2018-0017","article-title":"The potential of biomimetic nanoparticles for tumor-targeted drug delivery","volume":"13","author":"Li","year":"2018","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.mtbio.2025.101726_bib71","doi-asserted-by":"crossref","first-page":"2304040","DOI":"10.1002\/advs.202304040","article-title":"Cell surface engineering tools for programming living assemblies","volume":"10","author":"Almeida\u2010Pinto","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib72","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/acs.accounts.4c00293","article-title":"Engineering cells for cancer therapy","volume":"57","author":"Hu","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mtbio.2025.101726_bib73","doi-asserted-by":"crossref","DOI":"10.2174\/1389557523666230203145645","article-title":"Application of cell membrane-coated nanomaterials for tumor treatment","volume":"23","author":"Zhu","year":"2023","journal-title":"MRMC"},{"key":"10.1016\/j.mtbio.2025.101726_bib74","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/molecules28052336","article-title":"Cell membrane biomimetic nanoparticles with potential in treatment of Alzheimer\u2019s disease","volume":"28","author":"Zhong","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2025.101726_bib75","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s40843-016-5163-4","article-title":"Cell membrane-coated nanoparticles for tumor-targeted drug delivery","volume":"60","author":"Chai","year":"2017","journal-title":"Sci. China Mater."},{"issue":"4","key":"10.1016\/j.mtbio.2025.101726_bib76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics8040036","article-title":"Evaluation of extrusion technique for nanosizing liposomes","volume":"8","author":"Ong","year":"2016","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.mtbio.2025.101726_bib77","doi-asserted-by":"crossref","first-page":"2006484","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane\u2010coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.101726_bib78","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1039\/D4TB01063A","article-title":"Preparation and characterization of macrophage membrane camouflaged cubosomes as a stabilized and immune evasive biomimetic nano-DDS","volume":"12","author":"Rui","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2025.101726_bib79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/pharmaceutics16040531","article-title":"Cell membrane-coated biomimetic nanoparticles in cancer treatment","volume":"16","author":"Zhang","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.101726_bib80","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1039\/C4NR07027E","article-title":"Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane","volume":"7","author":"Fu","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.mtbio.2025.101726_bib81","doi-asserted-by":"crossref","first-page":"688070","DOI":"10.3389\/fcell.2021.688070","article-title":"Surface PEGylated cancer cell membrane-coated nanoparticles for codelivery of curcumin and doxorubicin for the treatment of multidrug resistant esophageal carcinoma","volume":"9","author":"Gao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mtbio.2025.101726_bib82","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1039\/C3LC50566A","article-title":"Microfluidic electroporation for cellular analysis and delivery","volume":"13","author":"Lu","year":"2013","journal-title":"Lab Chip"},{"key":"10.1016\/j.mtbio.2025.101726_bib83","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.mtbio.2025.101726_bib84","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/acsnano.2c09033","article-title":"Tumor\u2013antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma","volume":"17","author":"Ma","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib85","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1021\/acsami.2c22363","article-title":"Surgically derived cancer cell membrane-coated R837-loaded poly(2-oxazoline) nanoparticles for prostate cancer immunotherapy","volume":"15","author":"Li","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.101726_bib86","first-page":"299","article-title":"A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody","volume":"21","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib87","first-page":"337","article-title":"A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy","volume":"27","author":"Xu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib88","doi-asserted-by":"crossref","first-page":"2204585","DOI":"10.1002\/adma.202204585","article-title":"Herpesvirus\u2010mimicking DNAzyme\u2010loaded nanoparticles as a mitochondrial DNA stress inducer to activate innate immunity for tumor therapy","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib89","doi-asserted-by":"crossref","first-page":"149649","DOI":"10.1016\/j.bbrc.2024.149649","article-title":"Biomimetic delivery of emodin via macrophage membrane-coated UiO-66-NH2 nanoparticles for acute pancreatitis treatment","volume":"702","author":"Yang","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mtbio.2025.101726_bib90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jcis.2021.06.066","article-title":"Hybrid artificial cell-mediated epigenetic inhibition in metastatic lung cancer","volume":"603","author":"Peng","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib91","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","article-title":"Engineered macrophage-membrane-coated nanoparticles with enhanced PD-1 expression induce immunomodulation for a synergistic and targeted antiglioblastoma activity","volume":"22","author":"Yin","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.101726_bib92","doi-asserted-by":"crossref","first-page":"1801754","DOI":"10.1002\/smll.201801754","article-title":"Light\u2010triggered biomimetic nanoerythrocyte for tumor\u2010targeted lung metastatic combination therapy of malignant melanoma","volume":"14","author":"Liu","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.101726_bib93","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1021\/acsnano.9b08714","article-title":"Biomimetic rebuilding of multifunctional red blood cells: Modular design using functional components","volume":"14","author":"Guo","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib94","doi-asserted-by":"crossref","first-page":"1900172","DOI":"10.1002\/advs.201900172","article-title":"Biomimetic nanotherapies: red blood cell based core\u2013shell structured nanocomplexes for atherosclerosis management","volume":"6","author":"Wang","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib95","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2025.101726_bib96","doi-asserted-by":"crossref","first-page":"1701366","DOI":"10.1002\/adhm.201701366","article-title":"Broad\u2010spectrum neutralization of pore\u2010forming toxins with human erythrocyte membrane\u2010coated nanosponges","volume":"7","author":"Chen","year":"2018","journal-title":"Adv. Healthc Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib97","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2017.01.016","article-title":"Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection","volume":"263","author":"Zhang","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.mtbio.2025.101726_bib98","article-title":"Functionalized erythrocyte membrane-coated nanoparticles for the treatment of klebsiella pneumoniae-induced sepsis","volume":"13","author":"Jing","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mtbio.2025.101726_bib99","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1039\/D3SC02022C","article-title":"An erythrocyte membrane-camouflaged fluorescent covalent organic framework for starving\/nitric oxide\/immunotherapy of triple-negative breast cancer","volume":"14","author":"Yuan","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jconrel.2022.05.057","article-title":"Nano co-delivery of plumbagin and dihydrotanshinone I reverses immunosuppressive TME of liver cancer","volume":"348","author":"Han","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.mtbio.2025.101726_bib101","doi-asserted-by":"crossref","first-page":"1801389","DOI":"10.1002\/adfm.201801389","article-title":"Myeloid\u2010derived suppressor cell membrane\u2010coated magnetic nanoparticles for cancer theranostics by inducing macrophage polarization and synergizing immunogenic cell death","volume":"28","author":"Yu","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib102","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3390\/pharmaceutics15030943","article-title":"Immunogenic cell death photothermally mediated by erythrocyte membrane-coated magnetofluorescent nanocarriers improves survival in sarcoma model","volume":"15","author":"Sousa-Junior","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.101726_bib103","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2019.01.027","article-title":"Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation","volume":"296","author":"Liang","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.101726_bib104","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1021\/acsnano.0c05792","article-title":"Enhancing inflammation targeting using tunable leukocyte-based biomimetic nanoparticles","volume":"15","author":"Zinger","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib105","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.7150\/thno.22078","article-title":"Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery","volume":"8","author":"Martinez","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2025.101726_bib106","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mpaic.2021.10.019","article-title":"Physiology of red and white blood cells","volume":"23","author":"Armstrong","year":"2022","journal-title":"Anaesth. Intensive Care Med."},{"key":"10.1016\/j.mtbio.2025.101726_bib107","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.apsb.2017.12.001","article-title":"Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy","volume":"8","author":"Huang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2025.101726_bib108","doi-asserted-by":"crossref","first-page":"2101349","DOI":"10.1002\/adhm.202101349","article-title":"White blood cell membrane\u2010coated nanoparticles: Recent development and medical applications","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib109","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.actbio.2022.03.030","article-title":"Glycyrrhetinic acid nanoparticles combined with ferrotherapy for improved cancer immunotherapy","volume":"144","author":"Li","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2025.101726_bib110","doi-asserted-by":"crossref","first-page":"2003368","DOI":"10.1002\/adma.202003368","article-title":"T\u2010cell\u2010mimicking nanoparticles for cancer immunotherapy","volume":"32","author":"Kang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib111","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1016\/j.apsb.2024.04.009","article-title":"Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2025.101726_bib112","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/s41467-023-40814-9","article-title":"Cholesterol removal improves performance of a model biomimetic system to co-deliver a photothermal agent and a STING agonist for cancer immunotherapy","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.101726_bib113","doi-asserted-by":"crossref","first-page":"2102322","DOI":"10.1002\/adma.202102322","article-title":"A biomimetic aggregation\u2010induced emission photosensitizer with antigen\u2010presenting and hitchhiking function for lipid droplet targeted photodynamic immunotherapy","volume":"33","author":"Xu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib114","doi-asserted-by":"crossref","first-page":"188705","DOI":"10.1016\/j.bbcan.2022.188705","article-title":"Metabolic tricks of cancer cells","volume":"1877","author":"H\u00f6nigova","year":"2022","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.mtbio.2025.101726_bib115","doi-asserted-by":"crossref","first-page":"45523","DOI":"10.1021\/acsami.4c08842","article-title":"Homologous tumor cell-derived biomimetic nano-trojan horse integrating chemotherapy with genetherapy for boosting triple-negative breast cancer therapy","volume":"16","author":"Duan","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.101726_bib116","first-page":"1","article-title":"Metabolic features of cancer cells","volume":"38","author":"Wang","year":"2018","journal-title":"Cancer Commun"},{"key":"10.1016\/j.mtbio.2025.101726_bib117","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s12951-024-02835-4","article-title":"Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication","volume":"22","author":"Mengyuan","year":"2024","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.mtbio.2025.101726_bib118","doi-asserted-by":"crossref","first-page":"33875","DOI":"10.1021\/acsnano.4c07074","article-title":"Biomimetic nanovesicles synergize with short-term fasting for enhanced chemotherapy of triple-negative breast cancer","volume":"18","author":"Chiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib119","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12943-023-01909-5","article-title":"The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis","volume":"22","author":"Guo","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2025.101726_bib120","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.cmet.2022.11.003","article-title":"Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells","volume":"34","author":"Gong","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.mtbio.2025.101726_bib121","first-page":"232","article-title":"Mechanism of action of anticancer drugs at a cellular level","volume":"18","author":"Karnofsky","year":"1968","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mtbio.2025.101726_bib122","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1002\/agt2.631","article-title":"Biomimetic cell membrane decorated ZIF\u20108 nanocarriers with IR\u2010780 and doxorubicin loading for multiple myeloma treatment","volume":"5","author":"Gao","year":"2024","journal-title":"Aggregate"},{"key":"10.1016\/j.mtbio.2025.101726_bib123","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.apsb.2023.08.012","article-title":"Cancer cell membrane-coated bacterial ghosts for highly efficient paclitaxel delivery against metastatic lung cancer","volume":"14","author":"Ling","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2025.101726_bib124","doi-asserted-by":"crossref","first-page":"55890","DOI":"10.1021\/acsami.1c17498","article-title":"Immunotherapy for tumor metastasis by artificial antigen-presenting cells via targeted microenvironment regulation and T-cell activation","volume":"13","author":"Lu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.101726_bib125","first-page":"97","article-title":"A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens","volume":"16","author":"Li","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib126","doi-asserted-by":"crossref","first-page":"2205193","DOI":"10.1002\/smll.202205193","article-title":"Tumor antigen loaded nanovaccine induced NIR\u2010activated inflammation for enhanced antigen presentation during immunotherapy of tumors","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.mtbio.2025.101726_bib127","doi-asserted-by":"crossref","first-page":"2410841","DOI":"10.1002\/adfm.202410841","article-title":"Biomimetic tumor cell membrane\u2010encapsulated nanoparticles combine NIR\u2010II photothermal therapy and chemotherapy for enhanced immunotherapy in triple\u2010negative breast cancer","volume":"34","author":"Xiong","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mattod.2023.07.003","article-title":"Biomimetic multifunctional nanodrugs enable regulating abnormal tumor metabolism and amplifying PDT-induced immunotherapy for synergistically enhanced tumor ablation","volume":"68","author":"Liu","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.mtbio.2025.101726_bib129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/acsnano.2c08861","article-title":"Biomimetic nanosonosensitizers combined with noninvasive ultrasound actuation to reverse drug resistance and sonodynamic-enhanced chemotherapy against orthotopic glioblastoma","volume":"17","author":"Chen","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib130","doi-asserted-by":"crossref","first-page":"2204961","DOI":"10.1002\/advs.202204961","article-title":"Reversing T cell dysfunction to boost glioblastoma immunotherapy by paroxetine\u2010mediated GRK2 inhibition and blockade of multiple checkpoints through biomimetic nanoparticles","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib131","doi-asserted-by":"crossref","first-page":"2304971","DOI":"10.1002\/advs.202304971","article-title":"Triply enhanced immunotherapy via dual glycan reforming integrated with perforation","volume":"11","author":"Yang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib132","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tracli.2017.04.004","article-title":"Platelets and immunity: From physiology to pathology","volume":"24","author":"Chabert","year":"2017","journal-title":"Transfus. Clin. Biol."},{"key":"10.1016\/j.mtbio.2025.101726_bib133","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1021\/acsbiomaterials.4c01362","article-title":"Platelet membrane-camouflaged copper doped CaO2 biomimetic nanomedicines for breast cancer combination treatment","volume":"10","author":"Ren","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.mtbio.2025.101726_bib134","doi-asserted-by":"crossref","first-page":"2200416","DOI":"10.1002\/adhm.202200416","article-title":"Annexin V\u2010modified platelet\u2010biomimetic nanomedicine for targeted therapy of acute ischemic stroke","volume":"11","author":"Quan","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0035-1564835","article-title":"Platelet physiology","volume":"42","author":"Frelinger","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.mtbio.2025.101726_bib136","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41467-021-22311-z","article-title":"Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors","volume":"12","author":"Bahmani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.101726_bib137","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12951-022-01491-w","article-title":"Biomimetic doxorubicin\/ginsenoside co-loading nanosystem for chemoimmunotherapy of acute myeloid leukemia","volume":"20","author":"Chen","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.101726_bib138","doi-asserted-by":"crossref","first-page":"100935","DOI":"10.1016\/j.jpha.2024.01.003","article-title":"Platelet membrane biomimetic nanomedicine induces dual glutathione consumption for enhancing cancer radioimmunotherapy","volume":"14","author":"Li","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.mtbio.2025.101726_bib139","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1039\/D2BM01291J","article-title":"A ROS-responsive biomimetic nano-platform for enhanced chemo-photodynamic-immunotherapy efficacy","volume":"10","author":"Yan","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib140","doi-asserted-by":"crossref","first-page":"eadf6854","DOI":"10.1126\/sciadv.adf6854","article-title":"Active recruitment of anti\u2013PD-1\u2013conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapy","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2025.101726_bib141","first-page":"19","article-title":"Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine","volume":"10","author":"Lopes","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.mtbio.2025.101726_bib142","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.matt.2023.01.012","article-title":"Exosome membrane-coated nanosystems: Exploring biomedical applications in cancer diagnosis and therapy","volume":"6","author":"Shao","year":"2023","journal-title":"Matter"},{"key":"10.1016\/j.mtbio.2025.101726_bib143","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2021.08.024","article-title":"Exosome membrane-modified M2 macrophages targeted nanomedicine: Treatment for allergic asthma","volume":"338","author":"Pei","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.101726_bib144","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2024.02.015","article-title":"Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy","volume":"368","author":"Wang","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.101726_bib145","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1021\/acsnano.4c00699","article-title":"Iron oxide nanoparticles engineered macrophage-derived exosomes for targeted pathological angiogenesis therapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib146","doi-asserted-by":"crossref","first-page":"144871","DOI":"10.1016\/j.cej.2023.144871","article-title":"Exosome membrane-sheathed and multi-stimuli-responsive MnO2 nanoparticles with self-oxygenation and energy depletion abilities potentiate the sonodynamic therapy of hypoxic tumors","volume":"472","author":"Hoang","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.mtbio.2025.101726_bib147","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.apsb.2023.08.022","article-title":"Development of exosome membrane materials-fused microbubbles for enhanced stability and efficient drug delivery of ultrasound contrast agent","volume":"13","author":"Jang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2025.101726_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2025.101726_bib149","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12951-021-01095-w","article-title":"Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.101726_bib150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.actbio.2023.05.040","article-title":"pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity","volume":"166","author":"Zhang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2025.101726_bib151","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1021\/acsnano.1c00680","article-title":"Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles","volume":"15","author":"Li","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib152","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1021\/acs.nanolett.4c01511","article-title":"Black phosphorus quantum dot loaded bioinspired nanoplatform synergized with aPD-L1 for multimode cancer immunotherapy","volume":"24","author":"Cao","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.101726_bib153","doi-asserted-by":"crossref","first-page":"44689","DOI":"10.1021\/acsami.3c07379","article-title":"Cancer-erythrocyte membrane-mimicking Fe3O4 nanoparticles and DHJS for ferroptosis\/immunotherapy synergism in tumors","volume":"15","author":"Yu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2025.101726_bib154","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1021\/acsabm.0c01553","article-title":"Tailor-made cell-based biomimetic nanoprobes for fluorescence imaging guided colorectal cancer chemo-immunotherapy","volume":"4","author":"Wang","year":"2021","journal-title":"ACS Appl. Bio. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib155","doi-asserted-by":"crossref","first-page":"2300323","DOI":"10.1002\/adhm.202300323","article-title":"Fused cytomembrane\u2010camouflaged nanoparticles for tumor\u2010specific immunotherapy","volume":"12","author":"Ji","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib156","doi-asserted-by":"crossref","first-page":"2406047","DOI":"10.1002\/adma.202406047","article-title":"Bioinspired AIE nanomedicine: A burgeoning technology for fluorescence bioimaging and phototheranostics","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib157","article-title":"Cell membrane biomimetic nanomedicines for cancer phototherapy","volume":"1","author":"Chen","year":"2023","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.mtbio.2025.101726_bib158","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1021\/acsnano.3c00041","article-title":"Conjugation of macrophage-mimetic microalgae and liposome for antitumor sonodynamic immunotherapy via hypoxia alleviation and autophagy inhibition","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.101726_bib159","doi-asserted-by":"crossref","first-page":"119301","DOI":"10.1016\/j.biomaterials.2019.119301","article-title":"RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo\/photothermal therapy of breast cancer","volume":"217","author":"Liu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.101726_bib160","first-page":"132","article-title":"Immune-defensive microspheres promote regeneration of the nucleus pulposus by targeted entrapment of the inflammatory cascade during intervertebral disc degeneration","volume":"37","author":"Zhou","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib161","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1021\/acscentsci.9b00060","article-title":"Engineering magnetosomes for high-performance cancer vaccination","volume":"5","author":"Li","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.mtbio.2025.101726_bib162","doi-asserted-by":"crossref","first-page":"1803567","DOI":"10.1002\/adfm.201803567","article-title":"Platelet\u2010inspired nanocells for targeted heart repair after ischemia\/reperfusion injury","volume":"29","author":"Su","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib163","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1021\/acsnano.4c01229","article-title":"Genetically edited cascade nanozymes for cancer immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano."},{"key":"10.1016\/j.mtbio.2025.101726_bib164","doi-asserted-by":"crossref","first-page":"eabf7820","DOI":"10.1126\/sciadv.abf7820","article-title":"Genetically engineered cell membrane\u2013coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs","volume":"7","author":"Park","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2025.101726_bib165","first-page":"211","article-title":"CD47KO\/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy","volume":"22","author":"Liu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.101726_bib166","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jconrel.2023.08.055","article-title":"Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor","volume":"362","author":"Liu","year":"2023","journal-title":"J. Contr. Release"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425002856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425002856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:45:36Z","timestamp":1762634736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425002856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":166,"alternative-id":["S2590006425002856"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.101726","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.101726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101726"}}